Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events

Recruiting N/A Interventional Study
Ischemic Stroke TIA
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
70 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
3,300 (estimated)
Sponsor
Karolinska Institutet · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Stroke is one of the leading causes behind death and permanent disability in adults. Atrial fibrillation (AF) is the most common clinical arrhythmia and its prevalence is steeply increasing with age. Atrial fibrillation is associated with a manifold increase in the risk for stroke. It is considered important to investigate the heart rhythm in stroke survivors without previously known AF, because …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients aged ≥ 70 years * A diagnosis of ischemic stroke or TIA within 14 days from inclusion. Exclusion Criteria: * Previously diagnosed atrial fibrillation * Contraindication to oral anticoagulant treatment according to Summary of Product Characteristics. * Indication for…
Contacts

Johan Engdahl, MD, PhD

+46737593374

johan.engdahl@sll.se

CONTACT

Kajsa Strååt, MD

+46812350000

kajsa.straat@sll.se

CONTACT